Intended audience: global business, financial and trade mediaHERNEXEOS® (zongertinib) and JASCAYD® (nerandomilast) launched in H2, 2025Group net ...
Life, Inc., a clinical-stage biotechnology company developing highly selective T cell engagers (TCEs) to treat cancer and ...
Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand ...
One of St. Joseph’s top employers announced Monday that 60 employees in manufacturing and supply will no longer have roles moving forward. An official with Boehringer Ingelheim ...
Boehringer Ingelheim unveiled its evolved company brand this week, featuring the corporate claim: “Life forward.” The German pharma giant said the claim builds upon the company’s purpose of ...
The White House said Friday it’s adding three drugs for diabetes and lung disease to the self-pay platform TrumpRx, as the ...
Know a standout early-career pharma marketing pro? Submit your nominations for future "Rising Stars" honorees here. Chris Kraemer spent his early career working with clients from big-name consumer ...
Boehringer Ingelheim is handing over a total of 38.8 million euros ($42 million) to long-time partner OSE Immunotherapeutics for a preclinical anti-PD1/cytokine drug as well as to expand their ...
Boehringer Ingelheim’s drug candidate for human epidermal growth factor receptor 2 (HER2)-mutated non-small cell lung cancer (NSCLC) has demonstrated a durable response of more than 14 months while ...
Boehringer Ingelheim has tapped RetinAI to support its attempt to develop treatments for geographic atrophy (GA), striking a deal to apply artificial intelligence tools to its imaging data in a search ...
The preclinical, small molecule program offers a potential first-in-class, oral, precision immunometabolic approach to modulating disease-driving immune cells Deal includes upfront and milestone ...
FDA’s Fast Track Designation for the GLP-1/glucagon dual agonist underscores the urgent need for new treatment options to fulfill the unmet medical needs of people affected by NASH Boehringer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results